Interactions between IL-15 and TGF-beta signalling pathways reveal novel therapeutic strategies to boost anti-cancer immunity [ 2018 - 2020 ]

Research Grant

[Cite as]

Brief description This project will determine if new immune inhibitory checkpoints can be synergistically targeted with BRAFV600E inhibition to reactivate and allow NK cells to maximise their anti-tumour immune functions and prevent cancer spread. It is a completely novel approach that will allow for the more rational design of melanoma treatments that targets NK cells following surgery and local radiotherapy and/or chemotherapy.

Funding Amount $AUD 450,647.26

Funding Scheme Project Grants

Notes New Investigator Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]